BME
BlackRock Health Sciences Trust
43.10$
+1.2%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q2 17 | Q3 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q4 24 | Q2 25 | Q4 25 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | 0.0% | 18.5% | – | 12.5% | – | 61.2% | – | 11.5% | – | 17.7% | – | 8.7% | – | 14.1% | 14.1% | 151.2% | 556.5% | 141.1% | 18.1% | 153.4% | 16.5% | – | – | 8.9% | 69.8% | 12.6% | 8.9% | |
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | -100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 81.5% | 100.0% | 87.5% | 100.0% | 38.8% | 100.0% | 88.5% | 100.0% | 82.3% | 100.0% | 91.3% | 100.0% | 85.9% | 85.9% | 100.0% | -456.5% | 100.0% | 81.9% | 100.0% | 83.5% | 100.0% | – | 91.1% | 100.0% | 87.4% | 91.1% | |
| – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | 0.0% | 0.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 97.2% | 97.2% | 89.2% | 89.2% | 89.2% | 100.8% | 100.8% | 100.8% | 80.8% | 80.8% | 90.5% | 90.5% | 90.5% | 80.6% | 9.7% | 94.4% | 6.4% | 85.9% | 31.6% | 113.1% | 6.1% | 94.7% | 9.3% | 103.8% | 4.5% | 80.5% | 7.3% | 7.3% | 79.7% | 293.6% | 72.4% | 13.8% | 78.9% | 35.9% | 78.8% | – | 152.3% | 75.5% | 11.2% | 9.2% | |
| 513.4% | 513.4% | 2,364.3% | 2,364.3% | 89.2% | 711.8% | -100.8% | 711.8% | 716.4% | 716.4% | 90.5% | 59.5% | 59.5% | 1,275.7% | -250.8% | 1,780.6% | 121.0% | 281.8% | 103.6% | 2,700.4% | 145.5% | 1,125.7% | 110.7% | 509.8% | 21.9% | 1,755.5% | 384.4% | 158.3% | 802.4% | 2,954.2% | 165.6% | 13.8% | 121.2% | 35.9% | 78.8% | – | 152.3% | 75.5% | -266.6% | 14.6% | |
| 2.4% | 2.4% | 10.8% | 10.8% | 10.8% | -0.8% | 0.8% | -0.8% | 19.2% | 19.2% | 9.5% | 9.5% | 9.5% | 19.4% | 332.3% | 5.6% | 255.6% | 14.1% | 280.8% | -13.1% | 301.7% | 5.3% | 241.1% | -3.8% | 52.3% | 19.5% | -298.5% | -298.5% | 20.3% | 6,646.1% | 27.6% | 68.1% | 21.1% | 47.6% | 21.2% | – | -61.2% | 24.5% | 354.0% | 76.4% | |
| – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | 0.0% | 0.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0% | 0.0% | – | – | – | 0.0% | 0.1% | 0.1% | |
| -413.4% | -413.4% | 2,464.3% | 2,464.3% | 2,464.3% | 811.8% | -811.8% | 811.8% | 816.4% | 816.4% | 159.5% | 159.5% | 159.5% | 1,375.7% | 332.2% | 1,880.6% | 0.0% | 381.8% | 0.0% | 2,800.4% | 0.0% | 1,225.7% | 0.0% | 609.8% | 0.0% | -1,655.5% | -298.5% | 0.0% | 902.4% | 6,644.7% | 265.6% | 68.1% | 221.2% | 47.6% | 1,133.1% | – | -61.3% | -90.0% | 353.9% | 76.4% | |
| -415.9% | -415.9% | 2,453.6% | 2,453.6% | 0.0% | 812.6% | 0.0% | 812.6% | 797.2% | 797.2% | 0.0% | 150.0% | 150.0% | 1,356.3% | -166.2% | 1,874.9% | 0.0% | 367.7% | 0.0% | 2,813.5% | 0.0% | 1,220.4% | 0.0% | 0.4% | 0.0% | -1,675.1% | 1.8% | 0.0% | 882.1% | 0.0% | 238.1% | 0.0% | 200.1% | 0.0% | – | – | – | – | – | – | |
| -413.4% | -413.4% | 2,464.3% | 2,464.3% | 2,464.3% | 811.8% | -811.8% | 811.8% | 816.4% | 816.4% | 159.5% | 159.5% | 159.5% | 1,375.7% | 332.2% | 1,880.6% | 62.5% | 381.8% | 298.7% | 2,800.4% | 50.9% | 1,225.7% | 73.7% | 609.5% | 35.6% | -1,655.5% | -298.5% | 64.7% | 902.4% | 6,644.7% | 265.6% | 68.1% | 221.2% | 47.6% | 1,133.1% | – | -61.3% | -90.0% | 353.9% | 76.4% | |
| -415.9% | -415.9% | 2,453.6% | 2,453.6% | – | 812.6% | – | 812.6% | 797.2% | 797.2% | – | 150.0% | 150.0% | 1,356.3% | 163.7% | 1,874.9% | 127.4% | 367.7% | 135.2% | 2,813.5% | 151.5% | 1,220.4% | 120.0% | 613.7% | 26.3% | -1,675.1% | -298.5% | -151.0% | 882.1% | 6,646.1% | 238.1% | 68.1% | 200.1% | 47.6% | – | – | -61.2% | 24.5% | 354.0% | 76.4% |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.